Webinar | November 21, 2019

Choosing The Right CDMO For Late Phase Clinical Trials

Source: Thermo Fisher Scientific

For many pharmaceutical companies that do not have their own facilities, choosing the right partner for late-phase clinical trials and commercial production is a critical aspect in the management of parenteral products. Oftentimes, small contract development and manufacturing organizations (CDMOs) can provide early-phase clinical material but do not have the ability to move through late stage and into commercialization.

This webinar will offer an insight into the importance of looking for a partner with extensive experience in the parenteral arena, as products move through clinical phases and toward commercialization. Learn how the right partner should be able to manage programs at all clinical stages, as well as have the ability and expertise in moving compounds from early-to late-clinical stage and through the process validation process to commercial launch. Watch the webinar to learn more.